Zimbabwe has rejected a significant US healthcare agreement valued at $367m (£272m) over five years because of the United States' insistence on sensitive information.
This move became public following a official document dated December was disclosed, which showed Head of State Emmerson Mnangagwa felt the arrangement was "unbalanced".
A government spokesman has since clarified that the United States was seeking biological samples for research and commercial purposes while was not willing to guarantee the resulting advantages from any future medical innovations.
"We are forced to start the difficult and regrettable process of scaling back our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had provided more than $1.9bn as health assistance to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has urged continued talks to reach a agreement agreeable to all parties so the country's vital HIV treatment initiative can continue.
Broader Context
This rejection follows a comparable case in neighbouring Kenya, where a high court blocked a similar deal with the US following concerns were filed about the security of Kenyans' health data.
After returning to the presidency recently, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
USAID had administered assistance for the US government, but Trump claimed its expenditure was "wasteful" and his government was seeking government-to-government agreements to boost transparency and responsibility.
Based on reports, 16 nations in Africa have so far signed similar health pacts, representing more than $18.3bn of fresh investment.
Specifics of the Rejected Deal
The funds for Zimbabwe would have funded "combating HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"It is our view this partnership would have delivered extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million presently on antiretroviral therapy through American-funded programmes," Tremont said.
However, government spokesperson Nick Mangwana argued the proposed deal was "unequal".
"The proposal required Zimbabwe to provide its biological resources and data over an extended period, with no corresponding promise of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might result from that shared data," Mangwana explained.
"In essence, our nation would supply the raw materials for medical research without any assurance that the end products would be available to our population if a future disease outbreak arise."
Sovereignty and Global Health
Mangwana further noted that the US's withdrawal from the global health body and its push of bilateral health agreements were upending structures previously established via the global health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing system designed to deal with future global health emergencies.
"This system is designed to guarantee that when a nation provides its data, the benefits – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the funds to develop them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We encourage ongoing dialogue with our American counterparts on how future co-operation could be arranged in a manner that respects the sovereignty and interests of each country."
Health Experts Reaction
Medical experts expressed it acknowledged the government's concerns, but recommended that talks must proceed considering a large portion of the country's HIV programmes relied on external financing.
"If technical issues exist, such as those relating to data governance or implementation frameworks, these can often be resolved through detailed discussion and negotiated safeguards," the group added.
The halted deal emphasises the continuing tensions between receiving much-needed international aid and protecting local interests in an increasingly interconnected world.